Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial.

Benzer Materyaller

• Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial.
  Yazar:: Monique Wasunna, ve diğerleri
  Baskı/Yayın Bilgisi: (2016-09-01)
• Parasitic loads in tissues of mice infected with Trypanosoma cruzi and treated with AmBisome.
  Yazar:: Sabrina Cencig, ve diğerleri
  Baskı/Yayın Bilgisi: (2011-06-01)
• The initial effectiveness of liposomal amphotericin B (AmBisome) and miltefosine combination for treatment of visceral leishmaniasis in HIV co-infected patients in Ethiopia: A retrospective cohort study.
  Yazar:: Charles Abongomera, ve diğerleri
  Baskı/Yayın Bilgisi: (2018-05-01)
• AmBisome^® Formulations for Pediatrics: Stability, Cytotoxicity, and Cost-Effectiveness Studies
  Yazar:: Guendalina Zuccari, ve diğerleri
  Baskı/Yayın Bilgisi: (2024-03-01)
• Safety and efficacy of single dose versus multiple doses of AmBisome for treatment of visceral leishmaniasis in eastern Africa: a randomised trial.
  Yazar:: Eltahir A G Khalil, ve diğerleri
  Baskı/Yayın Bilgisi: (2014-01-01)